This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. Here we take a look at the biggest mergers and acquisitions of 2020 and what they might mean for the companies involved.
The Swiss biotech is seeking a priority review for vamorolone, which was licensed from US biotech ReveraGen BioPharma in 2020 after Santhera its former DMD therapy candidate idebenone failed clinical testing and was abandoned. Its lead drug has already claimed fast track and rare paediatric disease designations from the FDA.
A 2022 study found that both B12 and B5 had protective effects against COVID infection, while a 2020 study found that vitamin B12 (when combined with vitamin D and magnesium) improved outcomes for elderly patients hospitalized with COVID-19. Vitamin C: Vitamin C is well known for its positive effects on the immune system.
Antioxidants are often associated with a healthy immune system, but they may also stave off disease by protecting cells from damage caused by free radicals. In a 2020 study , ellagic acid was shown to inhibit lung cancer cell proliferation and tumor growth. Does raspberry leaf interfere with medications?
Seagen’s deal is another endorsement of Lava’s Gammabody platform, which creates drug candidates that target immune cells known as gamma delta or V?9V?2 It comes after Johnson & Johnson’s Janssen Biotech division signed up to access the bispecific antibody technology in 2020, without revealing any financial details.
The field of immunotherapy is constantly evolving with the ultimate goal to develop new treatments that help the body’s immune system fight cancer. Immune cells, such as T cells and natural killer (NK) cells, have the inherent ability to combat diseases, including cancer, but are often inhibited by the body’s own suppressive mechanisms.
The US Food and Drug Administration (FDA) approved Kamada’s application to manufacture Cytogam (cytomegalovirus immune globulin intravenous [human]) at its facility located in Beit Kama, Israel. It is claimed to be the only immunoglobulin (IgG) product to receive FDA approval for this indication.
Shares in US biotech Verrica Pharma lost half their value today after the FDA declined to approve its candidate treatment for viral skin infection molluscum contagiosum for a third time. Sterling was classified by the FDA as voluntary action indicated (VAI) last November.
The US Food and Drug Administration (FDA) has accepted a priority review of the biologics license application (BLA) for Regeneron Pharmaceuticals ’ pozelimab to treat children and adults with ultra-rare CHAPLE disease. The post US FDA accepts Regeneron’s pozelimab BLA for priority review appeared first on Pharmaceutical Technology.
Inovio Pharma’s plan to start pivotal testing of its COVID-19 vaccine has been delayed by FDA requests for more information, sending its shares into a swift decline. Once inside the cell, the DNA plasmids instruct the cell to produce the targeted antigen, triggering an immune response against the antigen.
Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. Changes in standard and supportive care over the time period could also have skewed the results, said the FDA reviewer.
While the French MaaT Pharma has submitted further information to the FDA, its trial remains on hold. In November 2022, Ferring Pharmaceuticals’s Rebyota became the first FDA-approved microbiome-based therapeutic to treat recurrent CDI. But the approval came through after an FDA Advisory Committee meeting. with placebo.
CFI regulates the activity of the complement immune system which is over-activated in GA. It has been fast-tracked by the FDA. It’s worth noting also that Novartis already has a position in GA, which derives from its $280 million takeover of US startup Vedere Bio in 2020, although that programme is in preclinical development.
Overall, the mechanisms of action for amivantamab include ligand blocking, receptor degradation, and immune cell-mediated activity. 4 BsMAb amivantamab was designed to enhance adherence of tumour cells to macrophages and natural killer cells, to improve immune-cell mediated killing of cancer cells. 2020; 19(10): 2044–56.
With prospects for idebenone looking shaky, Santhera snapped up vamorolone from US biotech ReveraGen BioPharma in August 2020 , claiming worldwide rights to the nonhormonal steroid modulator in DMD and all other indications.
Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Javitt & Michael D. Shumsky & Philip Won & Adrienne R. Gaulkin & Jeffrey N.
In addition, the FDA label for the nighttime forms of Mucinex containing acetaminophen recommends avoiding three or more drinks per day. Effects on the immune system Alcohol may negatively affect your immune system’s ability to fight off infections, especially in people who drink large amounts over time.
BMS is best known as an early pioneer of checkpoint inhibitor therapies, which work by flipping a biochemical switch on tumour cells that suddenly makes them visible to the immune system, allowing T-cells to mount an attack.
The FDA has placed a partial clinical fold on clinical trials of Gilead Sciences’ magrolimab, the centre piece of its $4.9 billion acquisition of Forty Seven in 2020. The post FDA slaps hold on trials of Gilead’s CD47 drug magrolimab appeared first on.
Plus, they’re not immune to regular old headaches. Yoga A 2020 systematic review of research published in the European Journal of Obstetrics & Gynecology and Reproductive Biology suggests that yoga is safe during pregnancy—and may even improve pregnancy outcomes while reducing pain, stress, and symptoms of depression and anxiety.
SMi Reports: SMi Group have made the decision due to travel restrictions to open the conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on October 28 and 29 2020. SMi’s 3rd Annual Pharmaceutical Microbiology East Coast 2020. Conference: October 28th-29th, 2020.
Phenylephrine In September 2023, the FDA announced that a common decongestant found on shelves, phenylephrine, is not actually effective to decrease congestion. Fruits and vegetables are full of vitamins and nutrients (like vitamin C and beta carotene ) that can boost the immune system when you’re sick. Here’s what to skip.
Sweden’s Sobi has secured EU approval for Doptelet in primary chronic immune thrombocytopenia (ITP), an indication that the company expects to accelerate sales of the drug. According to some analysts it could catapult sales to several hundred million dollars a year, perhaps even broaching the $1 billion threshold.
Finally, Andreas looks at the prospects for antibodies that target the innate immune system in treating both haematological malignancies and solid tumours. Many cancer patients, however, lack a functional innate immune system, and do not have enough functional NK cells.
In its annual results statement, AZ said that it took the decision on the back of data showing that a third dose of Vaxzevria increased the immune response to new variants, including Omicron which is currently driving new COVID-19 cases around the world. ” Vaxzevria added almost $4 billion to its revenues last year, including $1.8
The US Food and Drug Administration (FDA) has approved Valneva SE’s IXCHIQ ® , the first chikungunya vaccine to be authorised in the world. The vaccine was granted PRIority MEdicine (PRIME) designation by the EMA in 2020. IXCHIQ-induced seroresponse was sustained over time with a 96.3
It is the first FDA-approved treatment for Zaire ebolavirus. Yancopoulos continued: “Our scientists realised that the science demanded they adapt these technologies to deliver the first FDA-approved recombinant monoclonal antibody treatment for any viral disease, and they picked one of the most challenging ones in Ebola.”.
Being pregnant doesn’t make you immune from allergies—and, in some cases, many find that their allergy symptoms actually get worse during pregnancy. The FDA is beginning to move away from that rating system, says Alyssa Dweck , MD, an OB-GYN and medical adviser for INTIMINA.
The therapy obtained conditional approval from the NMPA for two indications in December 2020. Additionally, it is being analysed in international Phase II trials to treat multiple sclerosis as well as in SLE, primary immune thrombocytopenia and neuromyelitis optica spectrum disorder trials in China.
The FDA has approved three prescription medicines for treating influenza , but one is reserved for hospitalized patients. It is considered an adaptogen that has antiviral, anti-inflammatory and immune modulating effects ( Pharmaceuticals , Sep. 8, 2020 ). But the question remains: what can you do if you catch the flu?
It may also boost your immune system, gut health, libido, and overall health. Immune function support There isn’t a lot of evidence of sea moss’ immune system support in human studies, but a 2018 study on Atlantic salmon found that dietary seaweed stimulated the immune response and helped them fight infection.
A chemical created by the immune system, histamines react when they encounter an allergen like pollen, dust, or mold. The FDA says Zyrtec’s effects typically last around 24 hours for humans, and studies show that its elimination half-life is around 8.3 Zyrtec works for dogs the same way it does for humans: blocking histamines.
Lykke Hinsch Gylvin, neuroscience global medical franchise head, Novartis, said: “Antibodies, also known as immunoglobulins, function as part of the healthy immune system, and reduced serum immunoglobulin levels have been previously linked to an apparent increased risk of infection. “We billion in 2019.
That contrasts with the approval awarded by the FDA, which opted for a broad indication that included first-line treatment for PNH, and positioned pegcetacoplan as a direct competitor to AstraZeneca/Alexion’s C5 inhibitors Soliris (eculizumab) and Ultomiris (ravulizumab) rather than a switch option.
Food and Drug Administration (FDA). Plus, many fruits are packed with vitamins and antioxidants that will boost your immune system if you’re fighting off a common cold or flu. Try some honey , Harvard Health (2020) Humidifiers and health , MedLine Plus (2022) Is rinsing your nasal passages with net pots safe?
GlaxoSmithKline has staked a claim to the fast-moving category of cancer therapies targeting the TIGIT immune checkpoint, agreeing a $2 billion plus licensing agreement with iTeos Therapeutics for an antibody candidate in early clinical development.
More than three decades ago, scientists at the National Cancer Institute began exploring ways to fight cancer using the patient’s immune system. CAGR between 2020 and 2028. It’s used primarily to monitor changes in immune cell phenotype, to monitor therapeutic cells, and to detect and monitor abnormal cells.
Allergens, he explains, trigger the release of chemicals like histamine from our mast cells (immune cells), leading to congestion and other inflammatory symptoms. Instead of taking vitamin C when you get sick, Dr. Husain says it’s a good idea to take a vitamin C supplement preventively because it boosts the immune system.
Steroid sprays All steroid nasal sprays previously required a prescription from your healthcare provider, but some have since received FDA approval for OTC use, such as Flonase (fluticasone propionate), Nasacort (triamcinolone), Nasonex (mometasone), and Rhinocort (budesonide). Others are still available with prescription only.
These foods will not necessarily cure sinus infections but complement other therapies by providing benefits such as solid immunity and reduced inflammation. Research has shown that getting enough rest is essential for your immune system to mount a defense against infections and inflammations.
But anemia in pregnancy doesn’t only affect the fetus; it can also increase your own risk of cardiac issues and immune system dysfunction and cause potential issues after your baby is born because of the blood loss during childbirth. A 2020 study found that intravenous iron infusions may help as well. According to the U.S.
Vitamin D supports the immune system by enhancing the pathogen-fighting effects of white blood cells, which are important parts of immune defense. Supplementing with vitamin D can especially help to improve mood and cognitive function during the winter months, as well as improve immune function. I recommend doses of 1.5
I knew he was right — sugar can contribute to a yeast overgrowth, lowered immunity, blood sugar issues, weight gain, diabetes, and a whole host of health problems (1-3) — but I was a sugar addict, and it was devastating to think that I would have to let go of this old friend and not have any sweetness in my life. An in vitro study.
This was followed by a further deal for the global development and commercialisation of another ADC, datopotamab deruxtecan (DS-1062) in 2020, with a deal value of up to $6bn. This is the first trial reporting the combined use of a TROP2-directed ADC with an immune checkpoint inhibitor for the treatment of NSCLC.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content